“Determination of the most informative prognostic parameters for assessing the status of the epidermal growth factor receptor Her2/neu in the primary tumor in breast cancer patients using the targeted radiopharmaceutical «99mTc-ADAPT6»”, Вопр. онкол., vol. 67, no. 3, pp. 368–373, Jul. 2021, doi: 10.37469/0507-3758-2021-67-3-368-373.